Elite Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	13.92	-4.31	20.11	3.56	8.9	5.09
Depreciation & Amortization	2.03	2.12	1.52	1.33	1.42	1.51
Other Amortization	0.01	0.01	-	0.01	0.01	0.01
Loss (Gain) From Sale of Assets	-	0.12	-	-	-	-0.05
Asset Writedown & Restructuring Costs	1.6	1.6	-	0.29	-	-
Stock-Based Compensation	0.23	0.23	6.75	0.58	0.78	0.94
Provision & Write-off of Bad Debts	0.88	0.15	0.24	-	-	-
Other Operating Activities	26.99	22.7	-19.96	-0.43	-3.6	-2.25
Change in Accounts Receivable	-20.31	-9.9	-16.6	-0.04	0.44	0.61
Change in Inventory	-4	-3.31	-3.38	-2.81	-1.73	-0.87
Change in Accounts Payable	1.44	0.24	0.02	1.34	0.31	-1.77
Change in Unearned Revenue	-0.01	-0.01	-0.01	-	-0.01	-0.18
Change in Other Net Operating Assets	-0.05	-2.18	8.07	-0.5	-0.02	0.15
Operating Cash Flow	22.73	7.46	-3.24	3.34	6.51	3.19
Operating Cash Flow Growth	427.24%	-	-	-48.70%	103.78%	-
Capital Expenditures	-1.08	-1.63	-0.81	-5.74	-0.5	-0.33
Sale of Property, Plant & Equipment	-	0.13	-	-	-	0.07
Sale (Purchase) of Intangibles	-	-0.9	-	-	-	-
Investing Cash Flow	-1.08	-2.4	-0.81	-5.74	-0.5	-0.26
Short-Term Debt Issued	-	-	4	-	-	-
Long-Term Debt Issued	-	-	-	14.44	-	1.01
Total Debt Issued	-	-	4	14.44	-	1.01
Long-Term Debt Repaid	-	-0.85	-0.66	-12.74	-0.67	-1.93
Total Debt Repaid	-4.75	-0.85	-0.66	-12.74	-0.67	-1.93
Net Debt Issued (Repaid)	-4.75	-0.85	3.34	1.7	-0.67	-0.91
Issuance of Common Stock	0.17	0.02	-	-	-	0.04
Financing Cash Flow	-4.58	-0.83	3.34	1.7	-0.67	-0.87
Net Cash Flow	17.08	4.23	-0.71	-0.7	5.34	2.06
Free Cash Flow	21.66	5.83	-4.04	-2.4	6.01	2.86
Free Cash Flow Growth	723.12%	-	-	-	109.85%	-
Free Cash Flow Margin	17.62%	6.94%	-7.14%	-7.02%	18.63%	11.28%
Free Cash Flow Per Share	0.02	0.01	-0.00	-0.00	0.01	0.00
Cash Interest Paid	0.43	0.67	0.12	1.1	0.18	0.18
Cash Income Tax Paid	0.91	0.61	0.29	0.42	-	-
Levered Free Cash Flow	6.67	-2.18	-4.87	-4.55	3.6	1.11
Unlevered Free Cash Flow	6.97	-1.71	-4.5	-3.87	3.71	1.26
Change in Working Capital	-22.93	-15.17	-11.89	-2.01	-1.01	-2.06

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.